Search results
Most patients stop using Wegovy, Ozempic for weight loss within two years, analysis finds
Reuters via Yahoo Singapore Finance· 5 days ago(Reuters) -Only one in four U.S. patients prescribed Novo Nordisk’s Wegovy or Ozempic for weight...
PepsiCo CEO: GLP-1 drugs are 'not impacting us'
Yahoo Finance· 4 days agoPepsiCo CEO Ramon Laguarta said GLP-1 drugs for weight loss and diabetes, such as Ozempic, Wegovy, and Mounjaro, aren't yet having an effect on the...
Eli Lilly awaits head-to-head study on GLP-1s after new report reaffirms superiority
Yahoo Finance· 6 days agoThe researchers said in the study that they focused on patients who went for follow-up visits to...
Pfizer (PFE) Moves Forward With Once-Daily Obesity Pill Study
Zacks via Yahoo Singapore Finance· 3 days agoPfizer PFE announced that it has selected its preferred once-daily modified-release formulation of...
...Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity...
Benzinga via Yahoo Singapore Finance· 4 days agoVivani Medical Inc. (NASDAQ:VANI) expects to initiate the first clinical study for the NPM-115...
Pfizer moving ahead with plans for once-daily weight loss pill
The Hill via Yahoo News Singapore· 4 days agoPfizer announced Thursday plans to move forward with an oral daily weight loss medication in the...
These weight-loss startups tell customers they can stop taking Ozempic or Wegovy and stay thin....
Fortune via Yahoo Singapore Finance· 6 days agoAs nearly $1 billion of venture capital dollars have been injected into weight-loss startups since...
As more and more weight-loss startups prescribe Ozempic and Wegovy, doctors say they’re making...
Fortune via Yahoo Singapore Finance· 5 days agoResearch on GLP-1s is still in its early stages, whether it be what happens when you’re on the...
Pfizer to move daily weight-loss pill to clinical trials
Evening Standard via Yahoo News Singapore· 4 days agoPfizer plans to move a version of its weight-loss pill danuglipron into clinical trials later this...
Trending tickers: Tesla, Nvidia, Pfizer and Superdry
Yahoo Finance UK· 3 days agoThe drug is one of several being developed by Pfizer but the company said its once-daily danuglipron treatment was the most advanced and had the...